SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).

/Pharmaceutical News Articles/ - MONROVIA, CA, October 10, 2007 - Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla is presenting at the Plenary Keynote session at GTCbio's 3rd Modern Drug Discovery and Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport.

Dr. James' presentation will focus on building and maintaining a high performance research and development organization. He will discuss the operating model used at Pfizer which includes approaches such as keeping the focus on the patient, accountability for strategy and delivery, and the alignment of research, development and commercial dimensions to ensure success. Dr. James' will also outline the importance of implementing clear performance expectations for organizations of any size.

The 3rd Modern Drug Discovery & Development Summit features over 150 speakers participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco - Kinetics, Dynamics, Genomics and Genetics. For more information, visit www.gtcbio.com.

Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website